|
市場調査レポート
商品コード
1672944
関節症性乾癬治療市場：薬剤クラス別、製品タイプ別、投与経路別、流通チャネル別、地域別Psoriatic Arthritis Treatment Market, By Drug Class, By Product Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
カスタマイズ可能
|
|||||||
| 関節症性乾癬治療市場：薬剤クラス別、製品タイプ別、投与経路別、流通チャネル別、地域別 |
|
出版日: 2025年02月19日
発行: Coherent Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
関節症性乾癬治療の世界市場は、2025年には121億9,000万米ドルと推定され、2032年には234億7,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR9.8%で成長すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年の市場規模 | 121億9,000万米ドル |
| 実績データ | 2020年から2024年まで | 予測期間 | 2025年から2032年 |
| 予測期間：2025年～2032年 CAGR： | 9.80% | 2032年の価値予測 | 234億7,000万米ドル |
乾癬性関節炎は、乾癬に伴って発症する慢性炎症性関節炎です。乾癬患者の約30%が乾癬性関節炎を発症すると推定されています。この疾患は、関節やその周辺の痛み、こわばり、腫れを引き起こします。乾癬性関節炎は時間の経過とともに関節に永続的な損傷を与える可能性があります。メトトレキサートやTNF阻害剤などの疾患修飾性抗リウマチ薬（DMARDs）を含む従来の治療は、症状を管理するために使用されます。世界の関節症性乾癬治療市場の成長は、より優れた安全性と有効性プロファイルを有する新規の標的生物学的製剤の開発・承認の高まりによって牽引されています。
市場力学：
世界の関節症性乾癬治療市場の成長は、世界の関節症性乾癬の有病率の増加が牽引しています。推定によると、この疾患の世界の有病率は0.06%から1%の間です。さらに、この疾患に対する認知度の向上と先進的な治療法の利用可能性も市場成長の原動力となっています。しかし、生物学的製剤は高価であるため、特に価格に敏感な新興国市場では市場成長の妨げとなる可能性があります。費用対効果の高い生物学的製剤のジェネリック医薬品を開発するために市場開拓企業が努力を続ければ、時間の経過とともにコストを削減することができます。さらに、新興国におけるヘルスケア支出の増加は、近い将来、市場プレーヤーに新たな機会を提供する可能性があります。
本調査の主な特徴
本レポートでは、世界の関節症性乾癬治療市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界の関節症性乾癬治療市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
本調査の対象となる主要企業には、ファイザー、ジョンソン・エンド・ジョンソン、アッヴィ、ノバルティス、UCB、イーライリリー、ブリストル・マイヤーズスクイブなどが含まれます。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界の関節症性乾癬治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の関節症性乾癬治療市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 影響分析
- 主なハイライト
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
第4章 世界の関節症性乾癬治療市場、薬剤クラス別、2020年-2032年、（10億米ドル）
- 生物学的製剤
- 非生物製剤
- 併用療法
第5章 世界の関節症性乾癬治療市場、製品タイプ別、2020年-2032年、（10億米ドル）
- 処方箋
- 店頭販売（OTC）
第6章 世界の関節症性乾癬治療市場、投与経路別、2020年-2032年、（10億米ドル）
- 非経口
- 経口
第7章 世界の関節症性乾癬治療市場、流通チャネル別、2020年-2032年、（10億米ドル）
- 病院薬局
- 小売薬局
- オンライン薬局
第8章 世界の関節症性乾癬治療市場、地域別、2020年-2032年、価値（10億米ドル）
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第9章 競合情勢
- Medtronic
- Johnson & Johnson（DePuy Synthes）
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
第10章 アナリストの推奨事項
- 機会
- アナリストの見解
- Coherent Opportunity Map
第11章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
Global Psoriatic Arthritis Treatment Market is estimated to be valued at USD 12.19 Bn in 2025 and is expected to reach USD 23.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 12.19 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.80% | 2032 Value Projection: | USD 23.47 Bn |
Psoriatic arthritis is a chronic inflammatory arthritis that occurs in conjunction with psoriasis. It is estimated that around 30% of people with psoriasis may develop psoriatic arthritis. The disease causes pain, stiffness and swelling in and around the joints. Over time, psoriatic arthritis can cause permanent damage to the joints. Conventional treatments including disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and TNF inhibitors are used to manage the symptoms. Global psoriatic arthritis treatment market growth is driven by rising development and approval of novel targeted biologic therapies with better safety and efficacy profiles.
Market Dynamics:
Global psoriatic arthritis treatment market growth is driven by growing prevalence of psoriatic arthritis worldwide. According to estimates, the global prevalence of the disease ranges between 0.06% to 1%. Moreover, increasing awareness about the disease and availability of advanced treatments can also drive the market growth. However, high cost of biologic therapies can hamper the market growth, especially in price-sensitive developing regions. Continued efforts by market players to develop cost-effective generic versions of biologics can reduce costs over time. Furthermore, rising healthcare expenditures in emerging nations can offer new opportunities for the market players in the near future.
Key features of the study:
This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global psoriatic arthritis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Eli Lilly, Bristol-Myers Squibb
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Biologics
- Non-biologics
- Combination Therapy
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Prescription
- Over-The-Counter (OTC)
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Parenteral
- Oral
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Johnson & Johnson (DePuy Synthes)
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Psoriatic Arthritis Treatment Market, By Drug Class
- Global Psoriatic Arthritis Treatment Market, By Product Type
- Global Psoriatic Arthritis Treatment Market, By Route of Administration
- Global Psoriatic Arthritis Treatment Market, By Distribution Channel
- Global Psoriatic Arthritis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Non-biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Psoriatic Arthritis Treatment Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Over-The-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Psoriatic Arthritis Treatment Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xtant Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- RTI Surgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SeaSpine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Arthrex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
